Hotel Shilla (008770)
Korea Stock Exchange · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 38,350.00 |
|---|---|
| 52-week range | 36,300.00 – 70,300.00 |
| Return, 1 month / 3 months | −7.8% / −18.8% |
| Return, 1 year / 3 years | −25.4% / −56.3% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 46.1% |
| Worst drawdown (1 year) | -46.8% |
| Average daily value traded | 9,117.58M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hotel Shilla is a South Korean hospitality company that operates luxury hotels and duty-free retail. Its hotel business runs properties in Seoul and on Jeju Island, serving business travellers, tourists and conference guests. The company also operates duty-free shops at airports and in city locations, selling cosmetics, fashion goods, liquor and other products to international travellers. Hotel Shilla is based in Seoul and is part of the Samsung group of companies.
The shares are listed on the Korea Stock Exchange in Korea under the code 008770, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hotel Shilla (008770) trades on the Korea Stock Exchange in Korea. It last closed at KRW 38,350.00 on 19 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 620 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.4% and over the last three months it fell 18.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.6% | ||
| From 52-week high | -44.7% | ||
| Momentum | 25 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.8% | ||
| 6-month return | -23.5% | ||
| 12-month return, skipping the last month | -19.1% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 46.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.8% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 9,117.58M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | −7.8% |
| 3 months | −18.8% |
| 6 months | −23.5% |
| 1 year | −25.4% |
| 3 years | −56.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 41,292.00 / 47,711.00 |
|---|---|
| Golden / death cross (60 days) | Death, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,100.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Dec 2023 | KRW 200.0000 |
| 28 Dec 2022 | KRW 200.0000 |
| 29 Dec 2021 | KRW 200.0000 |
| 29 Dec 2020 | KRW 200.0000 |
| 27 Dec 2019 | KRW 350.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.